Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by scientists* at Novo Nordisk in the C-terminal α-amination of peptides and ...
Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...
6d
AZoLifeSciences on MSNMutant Vimentin Promotes Aggressive Breast Cancer GrowthVimentin is a type III intermediate filament (IF) protein typically expressed in cells that differentiate into connective ...
DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...
Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...
Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.
Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and ...
Cysteine-Directed Isobaric Labeling Combined with GeLC-FAIMS-MS for Quantitative Top-Down Proteomics
Applied Bioinformatics, Computer Science Department, University of Tübingen, Sand 14, 72076 Tübingen, Germany Institute for Bioinformatics and Medical Informatics, University of Tübingen, Sand 14, ...
bats — which carry coronaviruses closely related to SARS-CoV-2 — the ISG15 protein is missing a cysteine amino-acid residue at position 78 (Cys78). Analyses of protein function revealed that ...
Regulatory amendments to a maximum residue limit (MRL) Footnote 1 are being proposed for tebuconazole as a result of the re-evaluation of tebuconazole in Canada. Tebuconazole is a systemic fungicide ...
Laboratory of Clinical Biochemistry and Metabolism, Department of General Pediatrics, Adolescent Medicine and Neonatology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg im ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results